Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations-Reference-Cited by-同舟云学术

Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations

Published:2016-09-05 Issue:1 Volume:13 Page:
ISSN:1542-6416
Container-title:Clinical Proteomics
language:en
Short-container-title:Clin Proteom

Author:

Cazares Lisa H.,Ward Michael D.,Brueggemann Ernst E.,Kenny Tara,Demond Paul,Mahone Christopher R.,Martins Karen A. O.,Nuss Jonathan E.,Glaros Trevor,Bavari Sina

Funder

U.S. Department of Defense

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Clinical Biochemistry,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12014-016-9119-8.pdf

Reference37 articles.

1. Group, F.I.S. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915–27.

2. Einstein MH, et al. Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years. Hum Vaccin. 2009;5(10):705–19.

3. Garcea RL, Gissmann L. Virus-like particles as vaccines and vessels for the delivery of small molecules. Curr Opin Biotechnol. 2004;15(6):513–7.